Showing results (341-350 of 353) with videos related to

Sort By:
Pageof 36
Blood|June 17, 2022
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trialStéphane de Botton, Pau Montesinos, Andre C Schuh, et al.
Oncotarget|January 1, 2017
5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemiaJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.
Diagnostics (Basel, Switzerland)|August 29, 2024
The Impact of Histologic Portal T-Cell Density on the Clinical Outcomes in Hepatic Graft-versus-Host Disease and Autoimmune Liver DiseasesSoon Kyu Lee, Sung-Soo Park, Silvia Park, et al.
Oncotarget|February 14, 2018
Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotypeJae-Sook Ahn, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, et al.
Haematologica|July 3, 2025
Serial next-generation sequencing for detecting germline predisposition in acute myeloid leukemiaJae-Sook Ahn, Joo Heon Park, ChangSun Lee, et al.
Scientific Reports|April 12, 2024
Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemiaGa-Young Song, Hyeon-Jong Kim, TaeHyung Kim, et al.
Hemasphere|August 5, 2021
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 TrialHartmut Döhner, Argiris Symeonidis, Dries Deeren, et al.
Annals of Hematology|May 28, 2016
Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide studyJa Min Byun, Young Jin Kim, Hwi-Joong Yoon, et al.
Blood|January 8, 2025
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AMLMark J Levis, Mehdi Hamadani, Brent R Logan, et al.
Blood Advances|July 30, 2026
Regional practice differences significantly impact benefit from post-HCT gilteritinib for FLT3-ITD AMLMark J Levis, Mehdi Hamadani, Brent R Logan, et al.
Pageof 36